Biotec Pharmacon presenting Woulgan® Biogel at BIO-Europe Spring 2012


CEO Svein W. F. Lien and Director IP & BD Alexander Bjørnå are presenting Biotec Pharmacon at BIO-Europe Spring 2012 in Amsterdam 20 and 21 March.

The presentation introduces Woulgan® Biogel as a novel and advanced wound healing product, its properties and market potential.

This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act).

For further information, please contact

CEO Svein W. F. Lien; mobile +47 922 89323



Documents & Links